The STAT3 isoform STAT3β has been described as a tumor suppressor, which can be a protective prognostic marker in acute myeloid leukemia, especially in ESCC patients with adjuvant chemoradiotherapy [27,29]. This evidence concerns the gene STAT3 and esophageal squamous cell carcinoma.